Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Biogen, Eisai, GSK, H. Lundbeck, Icecure, Nicox, Nutromics, Ocumension, Takeda, Telix, Viatris.